Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data

被引：0
|
作者：
Annunziata Dattola
Maria Vittoria Cannizzaro
Mauro Mazzeo
Luca Bianchi
机构：
[1] University of Rome “Tor Vergata”,Department of Dermatology
来源：
Dermatology and Therapy | 2018年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the original publication, part Fig. 3b and c were interchanged. The correct versions are given below.
引用
下载
收藏
页码：171 / 171
相关论文
共 50 条
  • [31] New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol
    Cauli, Alberto
    Piga, Matteo
    Lubrano, Ennio
    Marchesoni, Antonio
    Floris, Alberto
    Mathieu, Alessandro
    JOURNAL OF RHEUMATOLOGY, 2015, 42 : 70 - 72
  • [32] Treatment of patients with destructive arthritis with certolizumab pegol
    Schmeiser, T.
    Mueller-Ladner, U.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2010, 69 (07): : 653 - 656
  • [33] Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
    Connock, M.
    Tubeuf, S.
    Malottki, K.
    Uthman, A.
    Round, J.
    Bayliss, S.
    Meads, C.
    Moore, D.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 1 - 10
  • [34] Improvements in extraarticular manifestations of psoriatic arthritis over 96-weeks of certolizumab pegol treatment
    FitzGerald, Oliver
    Fleischmann, Roy
    Hoepken, Bengt
    Peterson, Luke
    Gladman, Dafna
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB255 - AB255
  • [35] An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
    Acosta-Felquer, Maria Laura
    Rosa, Javier
    Soriano, Enrique R.
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2016, 8 : 37 - 44
  • [36] THE EFFECT OF CERTOLIZUMAB PEGOL ON RADIOGRAPHIC PROGRESSION OVER 4 YEARS OF TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS
    van der Heijde, D.
    Fleischmann, R.
    Wollenhaupt, J.
    Deodhar, A.
    Bauer, L.
    Hoepken, B.
    Peterson, L.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1316 - 1316
  • [37] COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS, AND PSORIATIC ARTHRITIS IN ROMANIA
    Codreanu, C.
    Mogosanu, C.
    Joita, M.
    Purcaru, O.
    VALUE IN HEALTH, 2014, 17 (07) : A379 - A379
  • [38] Psoriasis Symptom Inventory (PSI) as a Patient-Reported Outcome in Mild Psoriasis: Real-life Data from a Large Psoriatic Arthritis Registry
    Aydin, Sibel
    Ureyen, Sibel
    Kalyoncu, Umut
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 922 - 922
  • [39] Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study
    D'Angelo, Salvatore
    Cantini, Fabrizio
    Ramonda, Roberta
    Cantarini, Luca
    Carletto, Antonio
    Chimenti, Maria Sole
    Delle Sedie, Andrea
    Foti, Rosario
    Gerli, Roberto
    Lomater, Claudia
    Lubrano, Ennio
    Marchesoni, Antonio
    Zabotti, Alen
    Salvarani, Carlo
    Scrivo, Rossana
    Scarpa, Raffaele
    Tramontano, Giuseppina
    Nannini, Carlotta
    Lorenzin, Mariagrazia
    Fabbroni, Marta
    Martinis, Federica
    Perricone, Roberto
    Carli, Linda
    Visalli, Elisa
    Rovera, Guido
    Perrotta, Fabio Massimo
    Quartuccio, Luca
    Altobelli, Alessio
    Costa, Luisa
    Niccoli, Laura
    Ortolan, Augusta
    Caso, Francesco
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [40] EFECTIVENESS AND RETENTION RATE OF CERTOLIZUMAB PEGOL IN SPONDYLOARTHRITIS. REAL LIFE DATA
    Exposito-Molinero, R.
    Garcia-Portales, R.
    Lamua-Riazuelo, J. R.
    Urruticoechea-Arana, A.
    Navarro-Alonso, P.
    Rey-Rey, J. S.
    Fernandez-Prada, M.
    Gonzalez Fernandez, C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1550 - 1550
12345